EURAZEO (EPA:RF) - EURAZEO PATRIMOINE SUPPORTS THE ACQUISITION OF THE BELLEDONNE CLINIC BY C2S GROUP
Directive transparence : information réglementée Opérations de l'émetteur (acquisitions, cessions...)
23/05/2019 17:40
Cliquez ici pour télécharger le pdf
Press release
EURAZEO PATRIMOINE SUPPORTS THE ACQUISITION OF THE BELLEDONNE CLINIC BY C2S
GROUP
Paris, May 23, 2019 - Eurazeo Patrimoine, Eurazeo's investment division
specializing in real estate and companies holding and operating real assets,
announces the acquisition of the Belledonne Clinic, located near Grenoble
(Isère, France) by C2S Group.
Created in 1967 in Saint-Martin-d'Hères, near Grenoble, the Belledonne Clinic
offers a diversified and comprehensive range of medical services organized
around seven activity sectors and particularly, cardiology, cancer surgery and
maternity services. It has a capacity of 290 medical beds and 23 procedure
rooms, thus becoming C2S Group's largest clinic. Its reputation is regularly
upheld by national private hospitals rankings.
With over 1,900 beds and places and an annual revenue of around EUR250 million,
C2S Group is a major private hospital player in France. It is present in the
Rhône-Alpes Auvergne and Bourgogne Franche- Comté regions, where it has 14
clinics. C2S Group comprises around 710 doctors, who are partners in the
Group's governance, and nearly 2,500 employees. Through its presence in the
Center-East region, combining state-of-the-art and local establishments, C2S
Group clinics treat over 300,000 patients each year.
Eurazeo Patrimoine has supported C2S's development since its acquisition in
March 2018, backing the Group's external growth policy and helping it invest in
capacity and modernization to strengthen the quality and attractiveness of its
clinics. Eurazeo Patrimoine contributes financial and human resources and its
investment and real estate transformation experience. The integration of the
Belledonne Clinic in the Group forms part of this strategy and is a major step
in C2S's development, confirming its position as a key player in the
Center-East region.
Renaud Haberkorn, Director of Eurazeo Patrimoine said: "We're delighted to
support C2S in its acquisition of the Belledonne Clinic, a top-tier asset both
on operations and real estate level. The management team has demonstrated its
ability to rapidly expand the Group, both organically and through instrumental
acquisitions. Eurazeo Patrimoine supports and encourages C2S Group to achieve
its ambitions."
Jean Rigondet, Chairman of C2S Group, added: "It is essential for patients to
be treated by talented practitioners, working together as a team, and to have
access to well-organized and broad medical care. The acquisition of the
Belledonne Clinic provides us with a high-level, comprehensive technical
platform in Greater Grenoble. We're extremely proud to integrate this reference
clinic into our Group."
***
About Eurazeo
o Eurazeo is a leading global investment company, with a diversified portfolio
of EUR17 billion in assets under management, including nearly EUR11 billion
from third parties, invested in over 300 companies. With its considerable
private equity, real estate, private debt and fund of funds expertise,
Eurazeo accompanies companies of all sizes, supporting their development
through the commitment of its 235 professionals and by offering deep sector
expertise, a gateway to global markets, and a responsible and stable
foothold for transformational growth. Its solid institutional and family
shareholder base, robust financial structure free of structural debt, and
flexible investment horizon enable Eurazeo to support its companies over the
long term.
Eurazeo has offices in Paris, New York, Sao Paulo, Buenos Aires, Shanghai,
London, Luxembourg, Frankfurt and Madrid.
o Eurazeo is listed on Euronext Paris.
o ISIN: FR0000121121 - Bloomberg: RF FP - Reuters: EURA.PA
About C2S Group
o C2S Group is a multi-regional group of clinics specializing in general
medicine and a leader in Auvergne- Rhône-Alpes and Burgundy Franche-Comté,
with 14 clinics. C2S Group is currently implementing a sustained acquisition
strategy to provide uniform and consistent geographic coverage. Medical
practitioners and health professionals in these two regions are closely
involved with the Group, which adopts a sustainable and high- performing
outlook to human health. It has developed a patient-centric health ecosystem
and is committed to offering a comprehensive range of treatments, which
anticipates the needs of each patient to provide healthcare excellence.
EURAZEO CONTACTS
CAROLINE COHEN
Head of Investor Relations
ccohen@eurazeo.com
Tel.: +33 (0)1 44 15 16 76
VIRGINIE CHRISTNACHT
Head of Communications
vchristnacht@eurazeo.com
Tel: +33 1 44 15 76 44
PRESS CONTACT
HAVAS PARIS
MAEL EVIN
E-mail: mael.evin@havas.com
Tel: +33 (0)6 44 12 14 91
For more information, please visit the Group's website: www.eurazeo.com
Follow us on Twitter, LinkedIn, and YouTube